Insilico Medicine Appoints Business Leader, Michelle Chen, as Chief Business Officer

HONG KONG and NEW YORK: HONG KONG and NEW YORK, Oct. 19, 2021 /PRNewswire/ -- Insilico Medicine, an end-to-end AI-powered drug discovery company, today announced the appointment of Dr. Michelle Chen to the company's position of Chief Business Officer. In this role, Dr. Chen will oversee the company's corporate strategies...

Click to view original post